Antimicrobial resistance is one of the leading challenges in the human healthcare segment. Advances in antimicrobial resistance have triggered exploration of natural alternatives to stabilize its seriousness. Antimicrobial peptides are small, positively charged oligopeptides that are as potent as commercially available antibiotics against a wide spectrum of organisms, such as Gram-positive bacteria, Gram-negative bacteria, viruses, and fungal strains. In addition to their antibiotic capabilities, these peptides possess anticancer activity, activate the immune response, and regulate inflammation. Peptides have distinct modes of action and fall into various categories due to their amino acid composition. Although antimicrobial peptides specifically target the bacterial cytoplasmic membrane, they can also target the cell nucleus and protein synthesis. Owing to the increasing demand for novel treatments against the threat of antimicrobial resistance, naturally synthesized peptides are a beneficial development concept. Antimicrobial peptides are pervasive and can easily be modified using de-novo synthesis technology. Antimicrobial peptides can be isolated from natural resources such as humans, plants, bacteria, and fungi. This review gives a brief overview of antimicrobial peptides and their diastereomeric composition. Other current trends, the future scope of antimicrobial peptides, and the role of d-amino acids are also discussed, with a specific emphasis on the design and development of new drugs.
1 December 2019 in Materials Chemistry and Physics
Bio-pigments are the colored primary and secondary metabolites released by microbes under stress conditions and are crucial for adaptation. Bio-pigments are being widely accepted for industrial utilization due to their natural form, organic source, and biodegradability. Also, the ease of cultivation, scalability and cost-effectiveness in terms of pigment extraction is bringing bio-pigments into the limelight. Chemical dyes are carcinogenic and pose a serious threat to human lives, which is another issue that environmentalists must address. However, bacterial pigments are safe to employ; therefore, the food, pharmaceutical, textile, and cosmetics sectors may all benefit from their applications. The therapeutic nature of bacterial pigments is revealed because of their antimicrobial, anticancer, cytotoxic, and remarkable antioxidant properties. Bio-pigments also have multifaceted properties and thus can be an attractive source for the next generation to live a sustainable life. The present review discusses the importance of bacterial pigments over synthetic dyes and their therapeutic and industrial potential. Extensive literature has been reviewed on the biomedical application of bacterial pigments, and further opportunities and future challenges have been discussed.
In this study, pigment-producing yeast (Rhodotorula alborubescens) was isolated from the soil sample, demonstrating the potential for carotenoid biosynthesis. Physiological, morphological, biochemical, and molecular characterization confirmed the identity of the isolate. Optimization of the physical parameters for carotenoid production was achieved through batch shake flask experiments. The optimal conditions were determined to be 84 h of incubation at pH 6.0 and 28 °C under white light irradiation, utilizing the Yeast Peptone Dextrose (YPD) medium composed of 10 g/L yeast extract, 5 g/L of peptone, and 5 g/L dextrose, resulting in maximum carotenoid content. Further, the presence of β-carotene was confirmed using High-Performance Liquid Chromatography and Fourier Transform Infrared Spectroscopy. These findings highlight the potential of the isolated soil yeast (R. alborubescens) as a potential source of carotenoids, offering natural alternatives for various industrial applications.
The role and characterization of serine racemase (SR) in eukaryotes and prokaryotes are well studied. Although, the phylogenetic distribution of serine racemase remains unexplored in prokaryotic and eukaryotic genomes. In this study, by using different computational software we explored the evolutionary history of serine racemases belonging to different life domains. For our analyses, we followed the rational selection criteria to generate a hierarchical dataset of SR-containing organisms. After screening, 193 species were selected and retrieved from an online database NCBI for further analysis. We found that human serine racemase homologs are distributed widely in all these different domains of organisms. Similarity and conservational results have proven that bacterial, fungal and protist SRs are more diverse as compared to mammalian and plant SRs, and those sharing <47% sequence identity are dehydratases rather than racemases. Data concerning the phylogenetic study has proven that serine racemase first evolves in bacteria with a 0.50 distance scale. This in-silico study gives a brief overview of the phylogenetic distribution of SRs.